FDA Approves New Alzheimer’s Drug That Slows Progression of the Disease

On January 6, 2023, the Food and Drug Administration approved the new Alzheimer’s drug lecanemab, which has been shown in clinical trials to slow cognitive decline in patients with mild cognitive impairment or early Alzheimer’s … [Read more...]

Blood Tests and a New Promising Drug for Alzheimer’s Are Here. Here’s What You Need to Know.

Q. I know Alzheimer’s research, diagnostic tools, and treatments have come a long way in the past few years, with several new options having been introduced. But, I’m curious — do any of these options really work or even show real … [Read more...]

Thank you for your upload